Dublin, Ireland, April 19, 2023 (GLOBE NEWSWIRE) -- Zion Market Research has published a new research report titled “Pleurodynia Treatment Market By Causes (Coxsackievirus B, Coxsackievirus A, And Echovirus), By Complications (Meningitis, Tachycardia, Hepatitis, Pericarditis, Myocarditis, And Orchitis)), By Symptoms (Chest Pain, Cough, Fever, Sore Throat, Headache, And Muscular Aches & Pains), And By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030” in its research database.

“According to the latest research study, the demand of global Pleurodynia Treatment Market size & share was valued at approximately USD 128.57 million in 2022. The market is expected to grow above a CAGR of 5.28% and is anticipated to reach over USD 191.58 million by 2030.”

The report analyses the pleurodynia treatment market’s drivers and restraints, as well as the impact they have on-demand throughout the projection period. In addition, the report examines global opportunities in the global market.

Pleurodynia Treatment Market Overview:

The pleurodynia treatment industry revolves around the production and use of drugs, therapies, and other treatment options that are used to manage the symptoms of pleurodynia which is also known as Bornholm disease. The condition is characterized by symptoms like fever, severe chest & abdominal pain, and muscle stiffness. It is caused by enteroviruses, such as Echovirus and Coxsackievirus B. Studies have shown that pleurodynia is self-restricted which means that it will cure on its own after some time.

Get a Free Sample PDF of this Research Report for more Insights - https://www.zionmarketresearch.com/sample/pleurodynia-treatment-market

(Before you plan to buy, sample reports are a great option to examine our in-depth studies or reports)

However, cases with severe symptoms require additional medical care. Currently, the healthcare sector does not have any accurate cure for the condition since there are no US Food & Drugs Administration (FDA)-approved drugs for the treatment. However, several antiviral drugs and other therapies may be used to manage the symptoms of the condition. The industry revolves around companies and organizations involved in the development, production, and distribution of these treatments along with healthcare professionals.

Our Free Sample Report Consists of the Following:

Report Scope:

Report Attributes Report Details
  
Report Name Pleurodynia Treatment Market Research Report
Market Size in 2022 USD 128.57 Million
Market Forecast in 2030 USD 191.58 Million
Growth Rate CAGR of 5.28%
Number of Pages 199
Key Companies Covered Roche Holding AG, Gilead Sciences, AbbVie, GlaxoSmithKline, Bristol Myers Squibb, Johnson & Johnson, Boehringer Ingelheim, Pfizer, Novartis, Takeda Pharmaceuticals, Merck & Co., Bayer, Teva Pharmaceutical Industries, AstraZeneca, Amgen, Eli Lilly and Company, Sanofi, Daiichi Sankyo, and Astellas Pharma.
Segments Covered By Causes, By Complications, By Symptoms, And By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA)
Base Year 2022
Historical Year 2016 to 2020
Forecast Year 2023 - 2030
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Key Insights from Primary Research

Directly Purchase a Copy of the Report | Quick Delivery Available - https://www.zionmarketresearch.com/buynow/su/pleurodynia-treatment-market

Industry Dynamics:

Growth Drivers

The global pleurodynia treatment market is projected to grow owing to increasing awareness about the condition. The industry is relatively new and the symptoms of pleurodynia can be easily associated with other conditions since the symptoms are very common. However, the growing number of cases has led to the government and healthcare industry undertaking several initiatives targeting the generation of mass awareness related to the condition and the treatment methods that can be used. Furthermore, the healthcare sector is also investing in various research activities to understand the virus and develop novel drugs and therapies that can provide accurate care.

The pleurodynia treatment industry may also benefit from the overall growing investments in healthcare infrastructure witnessed across the globe. Countries are investing in deploying more effective treatment solutions due to increased pressure caused by growing expectations and demand from patients for adequate care. In addition to this, advances in technology are expected to drive the development of new treatments for pleurodynia. For instance, the use of artificial intelligence and machine learning could help to identify new drug targets and develop more effective treatments.

To know more about this report | Request A Free Sample Copy

Restraints

One of the key drawbacks in the industry is the availability of only limited treatment options. Currently, there are no remedies for treating the condition from its root. The medicines available in the pleurodynia treatment market only assist in managing the associated symptoms or pain relief. The patient may have to deal with the condition on their own and wait for it to subside in case of an absolute lack of access to medical care. This is further affected by the lack of adequate awareness amongst the population and healthcare professionals, especially in emerging economies.

Opportunities & Challenges

The growing investment toward novel therapies may prove growth opportunities while the regulatory challenges could restrict market expansion.

Pleurodynia Treatment Market: Segmentation Analysis

The global pleurodynia treatment market is segmented based on causes, complications, symptoms, and region.

Based on causes, the global market segments are Coxsackievirus B, Coxsackievirus A, and echovirus. In 2022, the industry witnessed the highest growth in the Coxsackievirus B segment since it is considered the largest cause of the condition. Various studies have indicated that more than 90% of the cases of pleurodynia are caused by Coxsackievirus B while the rest of the two reasons remain relatively low in terms of leading cause. The virus is a member of the enterovirus family and exists alongside Coxsackievirus A and Echovirus. It can be easily transmitted through close contact with an infected patient or from contaminated food or water, and surfaces. The infected patient may suffer from various symptoms including fever, headache, muscle aches, and respiratory concerns.

Based on complications, the pleurodynia treatment industry divisions are meningitis, tachycardia, hepatitis, pericarditis, myocarditis, and orchitis. In 2022, the industry witnessed the highest growth in the pericarditis and myocarditis segments. The former refers to the inflammation of the heart-surrounding sac whereas the latter is the inflammation of the heart muscle itself. The complications include symptoms like chest pain and heart failure and can be serious if not handled with precaution. The rest of the complications like meningitis, tachycardia, hepatitis, and orchitis are not very common but it is important to note that every patient's case history is different from the rest.

Based on symptoms, the global market divisions are chest pain, cough, fever, sore throat, headache, and muscular aches & pain.

Browse Complete Report Here | Pleurodynia Treatment Market By Causes, By Complications, By Symptoms, and By Region - Global And Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, And Forecasts 2023 – 2030

Regional Analysis:

North America is anticipated to lead the global pleurodynia treatment market due to the high incidence rate of the condition and the presence of well-established healthcare infrastructure. In addition to this, the increasing investment in R&D activities and the presence of major pharmaceutical companies in the region are expected to drive regional market growth. Europe is also expected to be a significant market for pleurodynia treatment due to the increasing prevalence of the condition in the region.

The presence of favorable government policies and reimbursement schemes, as well as the increasing investment in healthcare infrastructure. Growth in Asia-Pacific may be driven due to the presence of a large patient pool, increasing healthcare spending, and the rising adoption of advanced healthcare technologies.

Competitive Players:

The report contains qualitative and quantitative research on the global pleurodynia treatment market, as well as detailed insights and development strategies employed by the leading competitors.

Some of the main players in the global pleurodynia treatment market include;

Request for Customization on this Report as per your requirements - https://www.zionmarketresearch.com/custom/7149

(We tailor your report to meet your specific research requirements. Inquire with our sales team about customising your report.)

Recent Industry Developments:

The global pleurodynia treatment market is segmented as follows:

By Causes

By Complications

By Symptoms

By Region

Have Any Query? Ask Our Experts: https://www.zionmarketresearch.com/inquiry/pleurodynia-treatment-market

Key questions answered in this report:

Key Offerings:

Browse Other Related Research Reports from Zion Market Research

About Zion Market Research:

Zion Market Research is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Zion Market Research are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.

Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Contact Us:

Rushikesh Dorge

USA: +1 347 690-0211 | UK: +44 2032 894158 | Japan: +81 50 5806 9039 | India: +91 7768 006 007

Follow Us on - LinkedIn | Twitter | Facebook | Pinterest | YouTube

Read Our Blogs: https://zmrblog.com/